Upgrade to SI Premium - Free Trial

Novavax (NVAX)

11.43 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/5/26)

Latest Headlines

U.S. biotech SMids: Q3 earnings preview October 18, 2026 8:00 PM - StreetInsider Form SCHEDULE 13G NOVAVAX INC Filed by: SHAH CAPITAL MANAGEMENT October 16, 2026 4:31 PM - SEC Filing Form SCHEDULE 13D/A NOVAVAX INC Filed by: SHAH CAPITAL MANAGEMENT October 16, 2026 4:15 PM - SEC Filing Novavax and Moderna shares fall after plague concerns ease, Citi comments October 7, 2026 5:06 AM - StreetInsider Novavax's Nuvaxovid wins approval in U.S., EU, Japan for 2026-2027 August 28, 2026 8:30 AM - StreetInsider Novavax's Partnership Strategy Continues to Deliver with XFG-adapted Nuvaxovid™ Approvals in the U.S., EU and Japan for 2026-2027 Vaccination Season August 28, 2026 8:30 AM - PR NewsWire Novavax (NVAX) 11K contracts of August 28 weekly 9 calls trade, share price up 8.8% August 19, 2026 3:20 PM - StreetInsider Form SCHEDULE 13G NOVAVAX INC Filed by: STATE STREET CORP August 7, 2026 10:26 AM - SEC Filing Form S-8 NOVAVAX INC August 6, 2026 4:01 PM - SEC Filing Novavax (NVAX) Tops Q2 EPS by 8c August 6, 2026 8:09 AM - StreetInsider Form 8-K NOVAVAX INC For: Aug 06 August 6, 2026 8:04 AM - SEC Filing Novavax Reports Second Quarter 2026 Financial Results and Operational Highlights August 6, 2026 8:00 AM - PR NewsWire Form 10-Q NOVAVAX INC For: Jun 30 August 6, 2026 7:50 AM - SEC Filing Novavax to Report Second Quarter 2026 Financial Results on August 6, 2026 July 30, 2026 7:00 AM - PR NewsWire Full Article List